Diphtheria toxin‐based anti‐human CD 19 immunotoxin for targeting human CD 19 + tumors
Diphtheria toxin‐based anti‐human CD 19 immunotoxin for targeting human CD 19 + tumors
About this item
Full title
Author / Creator
Publisher
Hoboken: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
CD
19 is expressed on normal and neoplastic B cells and is a promising target for immunotherapy. However, there is still an unmet need to further develop novel therapeutic drugs for the treatment of the refractory/relapsing human
CD
19
+
tumors. We have developed a diphtheria toxin‐based anti‐human
CD
19 immunotoxin for targeti...
Alternative Titles
Full title
Diphtheria toxin‐based anti‐human CD 19 immunotoxin for targeting human CD 19 + tumors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2287918226
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2287918226
Other Identifiers
ISSN
1574-7891
E-ISSN
1878-0261
DOI
10.1002/1878-0261.12056
